Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03847636 · ClinicalTrials.gov registry record · NA
CryoBalloon Ablation for Treatment of Duodenal Adenomas
A NA study of Familial Adenomatous Polyposis and Duodenal Adenomas, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 4
- Study locations
NCT03847636 is a NA study of Familial Adenomatous Polyposis and Duodenal Adenomas that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 44 participants, below the 244-participant average among 10 other Familial Adenomatous Polyposis trials with a reported enrollment target (82% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT03847636, a NA study of Familial Adenomatous Polyposis and Duodenal Adenomas, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 4
- Study locations
Study Summary
This multicenter prospective non-randomized interventional study (clinical trial) that will assess the safety and efficacy of cryoballoon ablation treatment using the C2 Cryoballoon device (Pentax Medical Corporation) as an alternative primary treatment modality for sporadic and familial nonampullary nonpolypoid (flat) duodenal adenomas.
Conditions Studied
Interventions
- DEVICE CryoBalloon ablation
Study Locations (4)
Maryland
- Johns Hopkins Hospital - Baltimore
New York
- Northwell Health - Manhasset
Pennsylvania
- Geisinger Medical Center - Danville
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2026-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03847636
The ClinicalTrials.gov registry entry for NCT03847636 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 244-participant average among 10 other Familial Adenomatous Polyposis trials with a reported enrollment target (82% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Familial Adenomatous Polyposis appearing as the primary indexed condition, and to 1 intervention - of which CryoBalloon ablation is the first listed.
NCT03847636 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Maryland, New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03847636 about?
NCT03847636 is a clinical study titled "CryoBalloon Ablation for Treatment of Duodenal Adenomas". This multicenter prospective non-randomized interventional study (clinical trial) that will assess the safety and efficacy of cryoballoon ablation treatment using the C2 Cryoballoon device (Pentax Medical Corporation) as an alternative primary treatment modality for sporadic and familial nonampullar...
What is the current status of trial NCT03847636?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2019-05-13. Estimated completion is 2026-03.
What conditions does trial NCT03847636 study?
This clinical trial studies the following conditions: Familial Adenomatous Polyposis, Duodenal Adenomas.
What interventions are being tested in trial NCT03847636?
The interventions under investigation include: CryoBalloon ablation (DEVICE).
Who is sponsoring clinical trial NCT03847636?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03847636 being conducted?
This trial has 4 study locations across Maryland, New York, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Familial Adenomatous Polyposis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis
RECRUITING · NA
-
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
RECRUITING · NA
-
A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
RECRUITING
-
A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
RECRUITING
-
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
RECRUITING · Phase 1
-
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.